![1]()
News
FDA advisers set high bar for new opioids
January 21, 2020
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
![1]()
News
Vaping-linked lung injury: 2,172 cases, 42 deaths
November 14, 2019
Forty-two deaths from EVALI have been confirmed in 24 states and the District of Columbia.
![1]()
News
Fentanyl-related deaths show strong regional pattern
November 12, 2019
Overdose death rates for cocaine, heroin, and fentanyl are high in the East and low in the West.
![1]()
News
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
October 25, 2019
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications were combined.
![1]()
News
CDC reports most vaping lung disease linked to THC-containing cartridges
September 27, 2019
Most vaping cartridges were obtained on the street, from dealers, online, or from friends or social contacts.
News
Drug abuse–linked infective endocarditis spiking in U.S.
September 18, 2019
New cases doubled from 2002 to 2016, and those affected tended to be younger white males living in poverty.
![1]()
News
CDC finds that too little naloxone is dispensed
August 6, 2019
Despite increases in the number of naloxone prescriptions dispensed, many patients at risk for overdose are not offered the potentially life-saving treatment, according to an analysis of national retail pharmacy data.
News
Abuse rate of gabapentin, pregabalin far below that of opioids
June 19, 2019
SAN ANTONIO – “Both gabapentin and pregabalin are abused but at rates that are 6-56 times less frequent than for opioid analgesics,” wrote Dr. Kofi Asomaning.
![1]()
News
Opioid prescriptions declined 33% over 5 years
June 7, 2019
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association.
News
Racial, economic disparities found in buprenorphine prescriptions
May 8, 2019
Black patients and patients without private health insurance are less likely to receive a buprenorphine prescription for opioid use disorder.
